Cellular Biomedicine Group

Cellular Biomedicine Group is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. It is the result of the acquisition, transfer, commercialization, and advancement of thirty years of research and human treatment experience in cellular medicine. Its cellular research and development is the result of collaboration among scientists and doctors from the US, England, and China.

Cellular Biomedicine Group, Inc. (CBMG) CEO Bizuo Liu on Q2 2019 Results - Earnings Call Transcript

Cellular Biomedicine Group, Inc. (CBMG) CEO Tony Liu on Q1 2019 Results - Earnings Call Transcript

News for Cellular Biomedicine Group Stock (CBMG)